These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 20813067
21. Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: correlation with clinicopathologic features and tumor markers. Shimada H, Nakajima K, Ochiai T, Koide Y, Okazumi SI, Matsubara H, Takeda A, Miyazawa Y, Arima M, Isono K. Oncol Rep; 1998; 5(4):871-4. PubMed ID: 9625835 [Abstract] [Full Text] [Related]
22. CYFRA21-1 and CEA are useful markers for predicting the sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma. Yi Y, Li B, Wang Z, Sun H, Gong H, Zhang Z. Biomarkers; 2009 Nov; 14(7):480-5. PubMed ID: 19863186 [Abstract] [Full Text] [Related]
23. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma. Peng YH, Xu YW, Guo H, Huang LS, Tan HZ, Hong CQ, Li SS, Xu LY, Li EM. Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995 [Abstract] [Full Text] [Related]
24. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix. Liu CZ, Zeng HX, Zhao JJ, Rong Y, Mo ZL, Li LA, Zhang JQ. Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239 [Abstract] [Full Text] [Related]
26. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma. Zhou SL, Yue WB, Fan ZM, Du F, Liu BC, Li B, Han XN, Ku JW, Zhao XK, Zhang P, Cui J, Zhou FY, Zhang LQ, Fan XP, Zhou YF, Zhu LL, Liu HY, Wang LD. Dis Esophagus; 2014 Jun; 27(8):790-7. PubMed ID: 24147952 [Abstract] [Full Text] [Related]
27. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma]. Wang JY, Rong TH, Liang YR, Long H, Chen QL, Ma GW. Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458 [Abstract] [Full Text] [Related]
29. Detection of anti-CUEC-23 antibodies in serum of patients with esophageal squamous cell carcinoma: a possible new serum marker for esophageal cancer. Shimada H, Kagaya A, Shiratori T, Nomura F, Takiguchi M, Matsubara H, Hiwasa T. J Gastroenterol; 2009 May; 44(7):691-6. PubMed ID: 19407926 [Abstract] [Full Text] [Related]
30. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study. Wu LL, Liu X, Huang W, Lin P, Long H, Zhang LJ, Ma GW. J Cardiothorac Surg; 2020 May 26; 15(1):115. PubMed ID: 32456707 [Abstract] [Full Text] [Related]
31. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels. Ma Q, Liu W, Jia R, Jiang F, Duan H, Lin P, Zhang L, Long H, Zhao H, Ma G. World J Surg Oncol; 2016 May 05; 14():141. PubMed ID: 27151090 [Abstract] [Full Text] [Related]
40. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus. Kanda M, Koike M, Shimizu D, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Omae K, Yamada S, Nakayama G, Kodera Y. Ann Surg Oncol; 2020 Apr 05; 27(4):1233-1240. PubMed ID: 31650302 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]